Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Pac J Cancer Prev ; 24(10): 3437-3440, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37898848

ABSTRACT

BACKGROUND: Delays in breast cancer diagnosis can allow the disease to progress to an incurable stage. However, factors that cause patients to delay seeking treatment are unclear. In this study, we aimed to identify behavioral economic factors and personality characteristics of patients with breast cancer who had a delayed diagnosis. METHODS: We analyzed questionnaires completed by 41 patients with breast cancer. A delayed diagnosis was defined if the time between the first symptom and the medical visit was more than 6 months. RESULTS: We found 11 patients who had a delayed diagnosis. The significant characteristics associated with patients with breast cancer who had delayed diagnosis were: (i) less experience with breast cancer screening; (ii) progressive disease stage; and (iii) low time and future time preference. We found no significant behavioral economic factors other than time preference, and personality that differed between patients with breast cancer who did and did not have a delayed diagnosis. CONCLUSION: Low time preference rate is a characteristic of patients with breast cancer who had a delayed diagnosis.


Subject(s)
Breast Neoplasms , Humans , Female , Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Economics, Behavioral , Early Detection of Cancer , Surveys and Questionnaires , Personality , Delayed Diagnosis
2.
Surg Today ; 51(1): 159-164, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32880061

ABSTRACT

PURPOSE: In endoscopic surgery, surgeons occasionally encounter difficulties due to visual field obstruction by muscles or blood vessels. In these situations, specialized instruments that can effectively retract these obstructions are required. Recently, we developed a new detachable wire-rimmed retractor (KN retractor) for narrow-space surgery. METHODS: We evaluated the utility of this KN retractor in 15 patients with thyroid and parathyroid disease. Of those, five patients with papillary thyroid cancer had gasless endoscopic hemithyroidectomy with central node dissection, five underwent endoscopic total thyroidectomy for Graves' disease, and the remaining five received endoscopic parathyroidectomy with gas insufflation. RESULTS: Surgeons were able to perform meticulous operations in a satisfactory visual field supported by the KN retractor. In all patients, the strap muscles were preserved without cutting. The average operating time was 149, 154, and 81 min in patients who underwent hemithyroidectomy with central node dissection, total thyroidectomy, and parathyroidectomy, respectively. Gas insufflation was successfully completed in all cases while maintaining sufficient airtightness. CONCLUSIONS: The KN retractor is suitable for both the gasless lifting method and gas insufflation surgery in a narrow space. We believe that the KN retractor is a new device that will greatly improve the safety and shorten the operation time in endoscopic surgery.


Subject(s)
Endoscopy/instrumentation , Parathyroid Glands/surgery , Parathyroidectomy/instrumentation , Thyroid Cancer, Papillary/surgery , Thyroid Gland/surgery , Thyroidectomy/instrumentation , Aged , Female , Gases , Graves Disease/surgery , Humans , Insufflation/instrumentation , Insufflation/methods , Male , Middle Aged , Operative Time , Parathyroidectomy/methods , Thyroidectomy/methods
3.
J Hum Genet ; 66(5): 519-534, 2021 May.
Article in English | MEDLINE | ID: mdl-33177704

ABSTRACT

Our recent research has revealed that passenger strands of certain microRNAs (miRNAs) function as tumor-suppressive miRNAs in cancer cells, e.g., miR-101-5p, miR-143-5p, miR-144-5p, miR-145-3p, and miR-150-3p. Thus, they are important in cancer pathogenesis. Analysis of the miRNA expression signature of breast cancer (BrCa) showed that the expression levels of two miRNAs derived from pre-miR-99a (miR-99a-5p and miR-99a-3p) were suppressed in cancerous tissues. The aim of this study was to identify oncogenic genes controlled by pre-miR-99a that are closely involved in the molecular pathogenesis of BrCa. A total of 113 genes were identified as targets of pre-miR-99a regulation (19 genes modulated by miR-99a-5p, and 95 genes regulated by miR-99a-3p) in BrCa cells. Notably, FAM64A was targeted by both of the miRNAs. Among these targets, high expression of 16 genes (C5orf22, YOD1, SLBP, F11R, C12orf49, SRPK1, ZNF250, ZNF695, CDK1, DNMT3B, TRIM25, MCM4, CDKN3, PRPS, FAM64A, and DESI2) significantly predicted reduced survival of BrCa patients based upon The Cancer Genome Atlas (TCGA) database. In this study, we focused on FAM64A and investigated the relationship between FAM64A expression and molecular pathogenesis of BrCa subtypes. The upregulation of FAM64A was confirmed in BrCa clinical specimens. Importantly, the expression of FAM64A significantly differed between patients with Luminal-A and Luminal-B subtypes. Our data strongly suggest that the aberrant expression of FAM64A is involved in the malignant transformation of BrCa. Our miRNA-based approaches (identification of tumor-suppressive miRNAs and their controlled targets) will provide novel information regarding the molecular pathogenesis of BrCa.


Subject(s)
Breast Neoplasms/genetics , Estrogens , Gene Expression Regulation, Neoplastic/genetics , Genes, Tumor Suppressor , Intracellular Signaling Peptides and Proteins/genetics , MicroRNAs/genetics , Neoplasm Proteins/genetics , Neoplasms, Hormone-Dependent/genetics , Nuclear Proteins/genetics , Oncogenes , Progesterone , RNA, Neoplasm/genetics , Aminopyridines/administration & dosage , Aminopyridines/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Benzimidazoles/administration & dosage , Benzimidazoles/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Cell Line, Tumor , Down-Regulation , Female , Genes, erbB-2 , Humans , Intracellular Signaling Peptides and Proteins/biosynthesis , Intracellular Signaling Peptides and Proteins/physiology , Kaplan-Meier Estimate , MicroRNAs/physiology , Middle Aged , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/physiology , Neoplasms, Hormone-Dependent/drug therapy , Neoplasms, Hormone-Dependent/mortality , Neoplasms, Hormone-Dependent/pathology , Nuclear Proteins/biosynthesis , Nuclear Proteins/physiology , Piperazines/administration & dosage , Piperazines/therapeutic use , Prognosis , Progression-Free Survival , Pyridines/administration & dosage , Pyridines/therapeutic use , RNA Interference , RNA, Neoplasm/physiology , RNA, Small Interfering/genetics , Treatment Outcome
4.
Surg Today ; 50(7): 778-782, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31691138

ABSTRACT

In 2011, we developed bidirectional approach video-assisted neck surgery (BAVANS) for endoscopic thyroid cancer surgery. BAVANS combines two different approach pathways at 180 degrees to the cervical lesion for endoscopic thyroidectomy and complete cervical lymphadenectomy. We reported previously that the cranio-caudal approach is extremely useful for endoscopic complete lymph node dissection around the trachea. In 2014, we upgraded the initial BAVANS for better maneuverability and quality of lymph node dissection. A new high-tech rigid endoscope with a variable viewing direction (EndoCAMeleon™), has enabled us to reduce the camera port in the anterior neck while keeping the easy maneuverability and the same quality of central lymph node dissection (LND) as with the initial BAVANS. Endoscopic thyroid cancer surgery is now evolving concurrently with new visual technology.


Subject(s)
Endoscopy/methods , Lymph Node Excision/methods , Thyroid Neoplasms/surgery , Thyroidectomy/methods , Video-Assisted Surgery/methods , Endoscopy/instrumentation , Female , Humans , Lymph Node Excision/instrumentation , Male , Thyroidectomy/instrumentation , Video-Assisted Surgery/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...